Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
RxSight, Inc. (RXST)
USD4.97
+0.05 (+0.91%)
US NASDAQ Healthcare Medical - Devices
Address
100 Columbia 92656
Aliso Viejo, CA, US
Aliso Viejo, CA, US
CEO
Ronald Kurtz
Website
rxsight.com
IPO
2021-07-30
CIK 1111485 ISIN US78349D1072
Description
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
News Sentiment (7d)
11 articles
- Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors GuruFocus
- RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript Seeking Alpha
- Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors Business Wire
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs GlobeNewsWire
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs Globe News Wire
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.97
+0.05 (+0.91%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
931.9K
Beta
1.13
Float Shares
36.92M
Free Float %
89.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.56% | -8.21% | -16.54% | -26.92% | -43.06% | -45.30% | -58.55% | -75.17% | -64.38% | -64.38% | -64.38% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Hold
Price Targets & DCF
Current price
4.97
Low
9.00
+81.3%
Consensus
10.25
+106.4%
Median
10.50
+111.5%
High
11.00
+121.6%
Ratings Trend (MoM)
11% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 6 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 2 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 2 |
11.00
+121.6%
|
| Last Year | 5 |
10.60
+113.5%
|
| All Time | 21 |
52.57
+958.8%
|
Quality scores
Altman Z-Score
1.73
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-3.9% Q1'26: -18.5% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-33.8% Q1'26: -90.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-32.6% Q1'26: -37.7% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-28.9% Q1'26: -57.7% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-66.3% Q1'26: -118.4% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+5.9% Q1'26: +2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.28× Q1'26: -0.15× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 4 EPS Ana. |
Dec 2027 7 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
22.59M
est: 22.04M (+2.5%)
|
49.01M
est: 48.76M (+0.5%)
|
89.08M
est: 115.18M (-22.7%)
|
139.93M
est: 140.03M (-0.1%)
|
134.48M
est: 131.62M (+2.2%)
|
129.36M
128.23M – 130.44M
-1.7% YoY
|
142.20M
138.88M – 146.09M
+9.9% YoY
|
154.98M
154.88M – 155.08M
+9.0% YoY
|
| EBITDA |
-41.01M
est: -7.19M (-470.7%)
|
-57.78M
est: -15.90M (-263.4%)
|
-41.04M
est: -67.38M (+39.1%)
|
-23.76M
est: -81.92M (+71.0%)
|
-39.62M
est: -77.00M (+48.5%)
|
-75.68M
-76.31M – -75.02M
+1.7% YoY
|
-83.19M
-85.47M – -81.25M
-9.9% YoY
|
-90.67M
-90.73M – -90.61M
-9.0% YoY
|
| EBIT |
-45.00M
est: -7.51M (-499.2%)
|
-61.80M
est: -16.62M (-271.9%)
|
-45.28M
est: -68.94M (+34.3%)
|
-27.38M
est: -83.82M (+67.3%)
|
-38.84M
est: -78.79M (+50.7%)
|
-77.43M
-78.08M – -76.75M
+1.7% YoY
|
-85.12M
-87.44M – -83.13M
-9.9% YoY
|
-92.77M
-92.83M – -92.70M
-9.0% YoY
|
| Net Income |
-48.69M
est: -103.51M (+53.0%)
|
-66.76M
est: -101.98M (+34.5%)
|
-48.61M
est: -41.18M (-18.0%)
|
-27.46M
est: -32.25M (+14.9%)
|
-38.94M
est: -42.64M (+8.7%)
|
-57.05M
-61.46M – -53.65M
-33.8% YoY
|
-53.59M
-69.27M – -36.14M
+6.1% YoY
|
-51.42M
-53.41M – -42.73M
+4.0% YoY
|
| SGA |
32.81M
est: 23.13M (+41.8%)
|
58.67M
est: 51.18M (+14.6%)
|
74.80M
est: 116.36M (-35.7%)
|
101.43M
est: 141.47M (-28.3%)
|
112.65M
est: 132.98M (-15.3%)
|
130.69M
129.55M – 131.78M
-1.7% YoY
|
143.66M
140.31M – 147.59M
+9.9% YoY
|
156.57M
156.47M – 156.68M
+9.0% YoY
|
| EPS |
-1.78
est: -2.66 (+33.2%)
|
-2.41
est: -2.61 (+7.6%)
|
-1.41
est: -1.00 (-40.9%)
|
-0.71
est: -0.72 (+1.8%)
|
-0.95
est: -1.05 (+9.8%)
|
-1.40
-1.49 – -1.30
-32.7% YoY
|
-1.28
-1.68 – -0.88
+8.4% YoY
|
-1.19
-1.30 – -1.04
+6.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-10.96M
OE per share TTM
-0.27
Owner's Yield
-3.91%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
28.2%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
21
Total invested
3.78M
Insider transactions (90d)
1
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Peter Kolchinsky | 3.05M | 11.10% | — | 3.05M | — | 3.05M | HC, IN | Delaware | 2021-08-13 | ↗ |
| 2 | RA Capital Management, L.P. | 3.05M | 11.10% | — | 3.05M | — | 3.05M | IA, PN | Delaware | 2021-08-13 | ↗ |
| 3 | Rajeev Shah | 3.05M | 11.10% | — | 3.05M | — | 3.05M | HC, IN | Delaware | 2021-08-13 | ↗ |
| 4 | RA Capital Healthcare Fund, L.P. | 2.84M | 10.40% | — | 2.84M | — | 2.84M | PN | Delaware | 2021-08-13 | ↗ |
| 5 | (1) BlackRock, Inc. | 2.79M | 7.00% | — | — | 2.79M | — | HC | Delaware | 2024-10-22 | ↗ |
| 6 | Juliet Tammenoms Bakker | 2.51M | 9.10% | 18.4K | 2.49M | 18.4K | 2.49M | IN | — | 2021-08-13 | ↗ |
| 7 | Patrick G. Enright | 2.49M | 9.10% | — | 2.49M | — | 2.49M | IN | — | 2021-08-13 | ↗ |
| 8 | Artisan Investments GP LLC | 2.40M | 6.70% | — | 1.92M | — | 2.40M | HC | Delaware | 2024-02-12 | ↗ |
| 9 | Artisan Partners Asset Management Inc. | 2.40M | 6.70% | — | 1.92M | — | 2.40M | HC | Delaware | 2024-02-12 | ↗ |
| 10 | Artisan Partners Holdings LP | 2.40M | 6.70% | — | 1.92M | — | 2.40M | HC | Delaware | 2024-02-12 | ↗ |
| 11 | Artisan Partners Limited Partnership | 2.40M | 6.70% | — | 1.92M | — | 2.40M | IA | Delaware | 2024-02-12 | ↗ |
| 12 | (10) | 2.02M | 7.60% | — | 2.02M | — | 2.02M | OO | Delaware | 2022-02-14 | ↗ |
| 13 | 7.60%(1)(2) | 2.02M | 7.60% | — | 2.02M | — | 2.02M | IN | Delaware | 2022-02-14 | ↗ |
| 14 | Anthony Tamer | 2.01M | 7.34% | — | 2.01M | — | 2.01M | IN | Delaware | 2022-02-14 | ↗ |
| 15 | H.I.G. BioVentures – Calhoun, LLC | 2.01M | 7.34% | — | 2.01M | — | 2.01M | OO | Delaware | 2022-02-14 | ↗ |
| 16 | H.I.G.-GPII, Inc. | 2.01M | 7.34% | — | 2.01M | — | 2.01M | OO | Delaware | 2022-02-14 | ↗ |
| 17 | Sami Mnaymneh | 2.01M | 7.34% | — | 2.01M | — | 2.01M | IN | Delaware | 2022-02-14 | ↗ |
| 18 | Longitude Capital Partners II, LLC | 1.99M | 7.30% | — | 1.99M | — | 1.99M | OO | — | 2021-08-13 | ↗ |
| 19 | Longitude Venture Partners II, L.P. | 1.99M | 7.30% | — | 1.99M | — | 1.99M | PN | — | 2021-08-13 | ↗ |
| 20 | Lord, Abbett & Co. LLC | 1.98M | 5.51% | 1.74M | — | 1.89M | — | IA | Delaware | 2024-02-14 | ↗ |
| 21 | OrbiMed Capital LLC | 1.06M | 3.90% | 1.06M | — | 1.06M | — | IA | Delaware | 2022-02-11 | ↗ |
| 22 | Longitude Prime Fund, L.P. | 500.0K | 1.80% | — | 500.0K | — | 500.0K | PN | — | 2021-08-13 | ↗ |
| 23 | Longitude Prime Partners, LLC | 500.0K | 1.80% | — | 500.0K | — | 500.0K | OO | — | 2021-08-13 | ↗ |
| 24 | OrbiMed Advisors LLC | 321.0K | 1.20% | — | 321.0K | — | — | IA | Delaware | 2022-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
21
-142 vs prev Q
New positions
5
Closed positions
145
Increased
9
Reduced
8
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 913.1K +913.1K (+100.0%) | 9.51B +9.5B (+100.0%) | 2.23% +2.229 pp | 1.29% +1.290 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 2.71M +2.3K (+0.1%) | 28.19M +3.9M (+16.0%) | 6.60% -0.030 pp | 0.00% +0.000 pp | USD47.68 -78.1% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 2.23M +82.5K (+3.8%) | 23.23M +3.9M (+20.4%) | 5.44% +0.173 pp | 0.00% +0.000 pp | USD30.27 -65.6% | 18 qtrs — |
| 4 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.16M +403.6K (+23.0%) | 22.48M +6.7M (+42.6%) | 5.27% +0.962 pp | 0.03% +0.011 pp | USD18.67 -44.2% | 12 qtrs — |
| 5 | MILLENNIUM MANAGEMENT LLC | 2.13M -64.0K (-2.9%) | 22.18M +2.5M (+12.5%) | 5.20% -0.185 pp | 0.01% +0.001 pp | USD20.96 -50.3% | 18 qtrs — |
| 6 | NOMURA HOLDINGS INC | 2.00M +2.0M (+100.0%) | 20.84M +20.8M (+100.0%) | 4.88% +4.882 pp | 0.03% +0.028 pp | USD10.42 +0.0% | 3 qtrs — |
| 7 | NO STREET GP LP | 1.98M +350.0K (+21.5%) | 20.58M +6.0M (+40.9%) | 4.82% +0.833 pp | 1.39% +0.425 pp | USD18.42 -43.4% | 10 qtrs — |
| 8 | D. E. SHAW & CO., INC. | 1.88M +49.9K (+2.7%) | 19.63M +3.1M (+19.1%) | 4.60% +0.098 pp | 0.01% +0.002 pp | USD12.07 -13.7% | 11 qtrs — |
| 9 | POINT72 ASSET MANAGEMENT, L.P. | 1.23M +1.1M (+692.6%) | 12.83M +11.4M (+818.7%) | 3.00% +2.624 pp | 0.01% +0.012 pp | USD10.24 +1.8% | 16 qtrs — |
| 10 | CITADEL ADVISORS LLC | 1.05M -244.3K (-18.9%) | 10.90M -700.9K (-6.0%) | 2.55% -0.614 pp | 0.00% 0.000 pp | USD16.40 -36.5% | 15 qtrs — |
| 11 | BNP PARIBAS ARBITRAGE, SNC | 975.7K +71.9K (+8.0%) | 10.17M +2.0M (+25.1%) | 2.38% +0.164 pp | 0.00% +0.000 pp | USD15.44 -32.5% | 5 qtrs — |
| 12 | BANK OF AMERICA CORP /DE/ | 928.6K +206.2K (+28.5%) | 9.68M +3.2M (+49.0%) | 2.27% +0.494 pp | 0.00% +0.000 pp | USD14.28 -27.0% | 18 qtrs — |
| 13 | STATE STREET CORP | 849.0K +24.8K (+3.0%) | 8.85M +1.4M (+19.4%) | 2.07% +0.050 pp | 0.00% +0.000 pp | USD26.45 -60.6% | 18 qtrs — |
| 14 | DEUTSCHE BANK AG\ | 842.2K -125.4K (-13.0%) | 8.78M +77.2K (+0.9%) | 2.06% -0.319 pp | 0.00% 0.000 pp | USD28.11 -62.9% | 18 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 837.8K +98.5K (+13.3%) | 8.73M +2.1M (+31.4%) | 2.05% +0.231 pp | 0.00% +0.000 pp | USD27.07 -61.5% | 18 qtrs — |
| 16 | TWO SIGMA INVESTMENTS, LP | 798.4K +135.9K (+20.5%) | 8.32M +2.4M (+39.7%) | 1.95% +0.323 pp | 0.01% +0.003 pp | USD14.57 -28.5% | 12 qtrs — |
| 17 | MORGAN STANLEY | 765.0K -79.6K (-9.4%) | 7.97M +378.1K (+5.0%) | 1.87% -0.206 pp | 0.00% +0.000 pp | USD19.57 -46.8% | 18 qtrs — |
| 18 | TWO SIGMA ADVISERS, LP | 732.1K +1.9K (+0.3%) | 7.63M +1.1M (+16.2%) | 1.79% -0.005 pp | 0.01% +0.002 pp | USD12.57 -17.1% | 11 qtrs — |
| 19 | BAILLIE GIFFORD & CO | 693.1K +6.8K (+1.0%) | 7.22M +1.1M (+17.1%) | 1.69% +0.008 pp | 0.01% +0.001 pp | USD35.33 -70.5% | 8 qtrs — |
| 20 | UBS GROUP AG | 624.6K -110.6K (-15.0%) | 6.51M -100.8K (-1.5%) | 1.52% -0.280 pp | 0.00% +0.000 pp | USD12.79 -18.5% | 17 qtrs — |
| 21 | GOLDMAN SACHS GROUP INC | 565.2K +191.6K (+51.3%) | 5.89M +2.5M (+75.4%) | 1.38% +0.463 pp | 0.00% +0.000 pp | USD19.65 -47.0% | 12 qtrs — |
| 22 | NUVEEN, LLC | 531.7K +456.8K (+609.7%) | 5.54M +4.9M (+722.5%) | 1.30% +1.114 pp | 0.00% +0.001 pp | USD12.51 -16.7% | 4 qtrs — |
| 23 | BARCLAYS PLC | 473.6K +414.8K (+705.6%) | 4.93M +2.0M (+69.8%) | 1.16% +1.012 pp | 0.00% +0.000 pp | USD13.71 -24.0% | 16 qtrs — |
| 24 | FEDERATED HERMES, INC. | 425.6K +166.2K (+64.1%) | 4.44M +2.1M (+90.2%) | 1.04% +0.402 pp | 0.01% +0.003 pp | USD11.99 -13.1% | 11 qtrs — |
| 25 | ACADIAN ASSET MANAGEMENT LLC | 416.8K +137.9K (+49.4%) | 4.34M +1.8M (+73.3%) | 1.02% +0.333 pp | 0.01% +0.003 pp | USD9.47 +10.0% | 3 qtrs — |
| 26 | GRANDEUR PEAK GLOBAL ADVISORS, LLC | 390.6K -30.1K (-7.2%) | 4.07M +287.5K (+7.6%) | 0.95% -0.079 pp | 0.55% +0.040 pp | USD15.56 -33.0% | 5 qtrs — |
| 27 | BROWN CAPITAL MANAGEMENT LLC | 357.7K -413.5K (-53.6%) | 3.73M -3.2M (-46.2%) | 0.87% -1.020 pp | 0.31% +0.020 pp | USD37.53 -72.2% | 6 qtrs — |
| 28 | PARKMAN HEALTHCARE PARTNERS LLC | 351.7K -29.1K (-7.6%) | 3.66M +241.6K (+7.1%) | 0.86% -0.076 pp | 0.35% -0.008 pp | USD26.27 -60.3% | 15 qtrs — |
| 29 | TOCQUEVILLE ASSET MANAGEMENT L.P. | 300.0K +— (+0.0%) | 3.13M +429.0K (+15.9%) | 0.73% -0.004 pp | 0.05% +0.006 pp | USD8.99 +15.9% | 2 qtrs — |
| 30 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 291.0K +31.0K (+11.9%) | 3.03M +694.6K (+29.7%) | 0.71% +0.072 pp | 0.00% +0.000 pp | USD30.36 -65.7% | 18 qtrs — |
| 31 | NORTHERN TRUST CORP | 287.3K -25.8K (-8.2%) | 2.99M +178.7K (+6.3%) | 0.70% -0.067 pp | 0.00% +0.000 pp | USD27.92 -62.7% | 18 qtrs — |
| 32 | VITRUVIAN PARTNERS LLP | 278.9K +48.1K (+20.9%) | 2.91M +831.4K (+40.1%) | 0.68% +0.114 pp | 2.09% +0.650 pp | USD27.42 -62.0% | 5 qtrs — |
| 33 | HOLOCENE ADVISORS, LP | 263.4K +263.4K (+100.0%) | 2.74M +2.7M (+100.0%) | 0.64% +0.643 pp | 0.01% +0.006 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 34 | ONE FIN CAPITAL MANAGEMENT LP | 254.6K +— (+0.0%) | 2.65M +364.1K (+15.9%) | 0.62% -0.003 pp | 0.86% +0.106 pp | USD8.99 +15.9% | 2 qtrs — |
| 35 | JPMORGAN CHASE & CO | 252.6K +149.7K (+145.5%) | 2.63M +1.7M (+184.6%) | 0.62% +0.364 pp | 0.00% +0.000 pp | USD11.88 -12.3% | 18 qtrs — |
| 36 | JANE STREET GROUP, LLC | 238.0K +150.8K (+173.1%) | 2.48M +1.7M (+216.6%) | 0.58% +0.367 pp | 0.00% +0.000 pp | USD15.35 -32.1% | 12 qtrs — |
| 37 | Y-INTERCEPT (HONG KONG) LTD | 218.8K +84.0K (+62.3%) | 2.28M +1.1M (+88.1%) | 0.53% +0.203 pp | 0.05% +0.022 pp | USD11.56 -9.9% | 3 qtrs — |
| 38 | DIMENSIONAL FUND ADVISORS LP | 218.7K -120.9K (-35.6%) | 2.28M -774.1K (-25.4%) | 0.53% -0.300 pp | 0.00% 0.000 pp | USD35.75 -70.9% | 14 qtrs — |
| 39 | SCHONFELD STRATEGIC ADVISORS LLC | 218.7K -338.9K (-60.8%) | 2.28M -2.7M (-54.5%) | 0.53% -0.835 pp | 0.01% -0.018 pp | USD17.22 -39.5% | 13 qtrs — |
| 40 | JACOBS LEVY EQUITY MANAGEMENT, INC | 185.1K +185.1K (+100.0%) | 1.93M +1.9M (+100.0%) | 0.45% +0.452 pp | 0.01% +0.007 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 41 | ALGERT GLOBAL LLC | 163.1K +163.1K (+100.0%) | 1.70M +1.7M (+100.0%) | 0.40% +0.398 pp | 0.03% +0.027 pp | USD10.42 +0.0% | 7 qtrs — |
| 42 | CANADA PENSION PLAN INVESTMENT BOARD | 162.3K -16.5K (-9.2%) | 1.69M +83.8K (+5.2%) | 0.40% -0.043 pp | 0.00% +0.000 pp | USD12.17 -14.4% | 3 qtrs — |
| 43 | CARNEGIE LAKE ADVISORS LLC | 161.8K -32.5K (-16.7%) | 1.69M -60.7K (-3.5%) | 0.40% -0.082 pp | 0.64% -0.030 pp | USD11.20 -7.0% | 3 qtrs — |
| 44 | BRIDGER MANAGEMENT, LLC | 160.7K +160.7K (+100.0%) | 1.67M +1.7M (+100.0%) | 0.39% +0.392 pp | 1.08% +1.077 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 45 | JUMP FINANCIAL, LLC | 158.4K -42.6K (-21.2%) | 1.65M -156.4K (-8.7%) | 0.39% -0.107 pp | 0.02% -0.001 pp | USD22.40 -53.5% | 11 qtrs — |
| 46 | NEW YORK STATE COMMON RETIREMENT FUND | 158.2K +32.6K (+25.9%) | 1.65M +519.1K (+46.0%) | 0.39% +0.078 pp | 0.00% +0.001 pp | USD25.91 -59.8% | 18 qtrs — |
| 47 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 151.5K -36.9K (-19.6%) | 1.58M -114.8K (-6.8%) | 0.37% -0.093 pp | 0.02% -0.003 pp | USD11.52 -9.5% | 3 qtrs — |
| 48 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 131.4K +— (+0.0%) | 1.37M +187.9K (+15.9%) | 0.32% -0.002 pp | 0.00% +0.000 pp | USD16.86 -38.2% | 4 qtrs — |
| 49 | WELLS FARGO & COMPANY/MN | 108.5K -3.4K (-3.0%) | 1.13M +124.7K (+12.4%) | 0.26% -0.010 pp | 0.00% +0.000 pp | USD18.10 -42.4% | 18 qtrs — |
| 50 | CREATIVE PLANNING | 107.8K +8.6K (+8.6%) | 1.12M +231.3K (+25.9%) | 0.26% +0.020 pp | 0.00% +0.000 pp | USD9.70 +7.4% | 5 qtrs — |
| 51 | AQR CAPITAL MANAGEMENT LLC | 99.1K +73.1K (+280.7%) | 1.03M +798.8K (+341.2%) | 0.24% +0.178 pp | 0.00% +0.000 pp | USD16.71 -37.6% | 10 qtrs — |
| 52 | BANK OF NEW YORK MELLON CORP | 94.3K -12.1K (-11.3%) | 982.9K +26.4K (+2.8%) | 0.23% -0.031 pp | 0.00% +0.000 pp | USD26.10 -60.1% | 18 qtrs — |
| 53 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 90.9K +23.5K (+34.9%) | 947.4K +341.3K (+56.3%) | 0.22% +0.057 pp | 0.01% +0.001 pp | USD9.36 +11.3% | 8 qtrs — |
| 54 | WALLEYE CAPITAL LLC | 87.7K -50.7K (-36.6%) | 914.3K -330.0K (-26.5%) | 0.21% -0.126 pp | 0.00% -0.002 pp | USD17.66 -41.0% | 11 qtrs — |
| 55 | GSA CAPITAL PARTNERS LLP | 86.7K +14.2K (+19.6%) | 904.0K +252.0K (+38.7%) | 0.21% +0.034 pp | 0.08% +0.024 pp | USD24.29 -57.1% | 11 qtrs — |
| 56 | PDT PARTNERS, LLC | 82.8K -6.8K (-7.6%) | 863.2K +57.5K (+7.1%) | 0.20% -0.018 pp | 0.06% +0.005 pp | USD13.00 -19.8% | 6 qtrs — |
| 57 | BALYASNY ASSET MANAGEMENT L.P. | 81.8K -252.3K (-75.5%) | 852.7K -2.2M (-71.6%) | 0.20% -0.620 pp | 0.00% -0.003 pp | USD8.99 +15.9% | 5 qtrs — |
| 58 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 81.8K +31.9K (+64.0%) | 851.9K +403.9K (+90.1%) | 0.20% +0.077 pp | 0.00% +0.000 pp | USD19.93 -47.7% | 12 qtrs — |
| 59 | MARSHALL WACE, LLP | 77.3K +77.3K (+100.0%) | 805.8K +805.8K (+100.0%) | 0.19% +0.189 pp | 0.00% +0.001 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 60 | FIRST CITIZENS BANK & TRUST CO | 76.8K +— (+0.0%) | 800.4K +109.8K (+15.9%) | 0.19% -0.001 pp | 0.02% +0.002 pp | USD50.47 -79.4% | 8 qtrs — |
| 61 | VOYA INVESTMENT MANAGEMENT LLC | 71.3K -22.8K (-24.2%) | 742.6K -103.0K (-12.2%) | 0.17% -0.057 pp | 0.00% 0.000 pp | USD17.33 -39.9% | 11 qtrs — |
| 62 | RUSSELL INVESTMENTS GROUP, LTD. | 69.1K +53.2K (+335.4%) | 720.1K +577.4K (+404.7%) | 0.17% +0.130 pp | 0.00% +0.001 pp | USD11.31 -7.9% | 17 qtrs — |
| 63 | UBS ASSET MANAGEMENT AMERICAS INC | 64.5K +— (+0.0%) | 672.2K +92.2K (+15.9%) | 0.16% -0.001 pp | 0.00% +0.000 pp | USD26.37 -60.5% | 10 qtrs — |
| 64 | FORMULA GROWTH LTD | 60.0K +60.0K (+100.0%) | 625.2K +625.2K (+100.0%) | 0.15% +0.147 pp | 0.24% +0.241 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 65 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 52.3K +52.3K (+100.0%) | 544.5K +544.5K (+100.0%) | 0.13% +0.128 pp | 0.01% +0.007 pp | USD10.42 +0.0% | 4 qtrs — |
| 66 | SEI INVESTMENTS CO | 46.6K +10.1K (+27.7%) | 485.3K +157.6K (+48.1%) | 0.11% +0.024 pp | 0.00% +0.000 pp | USD18.83 -44.7% | 12 qtrs — |
| 67 | RHUMBLINE ADVISERS | 43.9K -7.6K (-14.7%) | 457.1K -5.3K (-1.1%) | 0.11% -0.019 pp | 0.00% +0.000 pp | USD24.00 -56.6% | 16 qtrs — |
| 68 | VERITION FUND MANAGEMENT LLC | 40.6K +1.7K (+4.4%) | 423.2K +73.4K (+21.0%) | 0.10% +0.004 pp | 0.00% +0.000 pp | USD23.46 -55.6% | 11 qtrs — |
| 69 | TREXQUANT INVESTMENT LP | 38.0K -73.3K (-65.9%) | 395.8K -604.9K (-60.4%) | 0.09% -0.181 pp | 0.00% -0.007 pp | USD24.64 -57.7% | 11 qtrs — |
| 70 | CI PRIVATE WEALTH, LLC | 36.1K +5.9K (+19.7%) | 376.1K +105.0K (+38.7%) | 0.09% +0.014 pp | 0.00% +0.000 pp | USD9.23 +12.9% | 2 qtrs — |
| 71 | QUEST PARTNERS LLC | 35.7K -2.4K (-6.2%) | 372.3K +29.9K (+8.7%) | 0.09% -0.006 pp | 0.02% -0.002 pp | USD15.18 -31.4% | 7 qtrs — |
| 72 | TEMPUS WEALTH PLANNING, LLC | 35.7K -5.2K (-12.8%) | 371.6K +4.0K (+1.1%) | 0.09% -0.013 pp | 0.09% +0.001 pp | USD14.44 -27.8% | 4 qtrs — |
| 73 | ALLIANCEBERNSTEIN L.P. | 35.6K +— (+0.0%) | 371.0K +50.9K (+15.9%) | 0.09% -0.001 pp | 0.00% +0.000 pp | USD40.33 -74.2% | 11 qtrs — |
| 74 | PRICE T ROWE ASSOCIATES INC /MD/ | 31.8K -1.8K (-5.3%) | 331.0K +29.0K (+9.6%) | 0.08% -0.005 pp | 0.00% +0.000 pp | USD23.70 -56.0% | 11 qtrs — |
| 75 | PALUMBO WEALTH MANAGEMENT LLC | 30.8K +6.8K (+28.5%) | 320.8K +105.4K (+48.9%) | 0.08% +0.016 pp | 0.08% +0.010 pp | USD9.31 +11.9% | 2 qtrs — |
| 76 | SQUAREPOINT OPS LLC | 30.3K -60.3K (-66.5%) | 315.8K -498.5K (-61.2%) | 0.07% -0.148 pp | 0.00% -0.001 pp | USD23.74 -56.1% | 10 qtrs — |
| 77 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 29.5K +7.9K (+36.4%) | 307.3K +113.0K (+58.1%) | 0.07% +0.019 pp | 0.00% +0.003 pp | USD11.16 -6.6% | 3 qtrs — |
| 78 | FMR LLC | 28.6K +7.1K (+33.3%) | 298.3K +105.2K (+54.5%) | 0.07% +0.017 pp | 0.00% +0.000 pp | USD33.61 -69.0% | 16 qtrs — |
| 79 | FOX RUN MANAGEMENT, L.L.C. | 28.6K -702.0 (-2.4%) | 297.7K +34.5K (+13.1%) | 0.07% -0.002 pp | 0.05% +0.005 pp | USD8.99 +15.9% | 9 qtrs — |
| 80 | MARINER, LLC | 27.2K -3.9K (-12.5%) | 283.5K +4.4K (+1.6%) | 0.07% -0.010 pp | 0.00% +0.000 pp | USD10.52 -1.0% | 12 qtrs — |
| 81 | QUANTBOT TECHNOLOGIES LP | 26.0K -120.2K (-82.2%) | 271.3K -1.0M (-79.4%) | 0.06% -0.295 pp | 0.01% -0.027 pp | USD17.05 -38.9% | 12 qtrs — |
| 82 | GRAHAM CAPITAL MANAGEMENT, L.P. | 25.1K +25.1K (+100.0%) | 261.5K +261.5K (+100.0%) | 0.06% +0.061 pp | 0.01% +0.006 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 83 | SUGAR MAPLE ASSET MANAGEMENT, LLC | 23.9K +23.9K (+100.0%) | 248.5K +248.5K (+100.0%) | 0.06% +0.058 pp | 0.17% +0.167 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 84 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 23.8K +5.2K (+27.9%) | 248.5K +80.9K (+48.3%) | 0.06% +0.013 pp | 0.00% +0.000 pp | USD9.30 +12.0% | 2 qtrs — |
| 85 | MML INVESTORS SERVICES, LLC | 23.2K +23.2K (+100.0%) | 241.3K +241.3K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.001 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 86 | QUANTINNO CAPITAL MANAGEMENT LP | 22.8K +4.6K (+25.6%) | 237.6K +74.3K (+45.5%) | 0.06% +0.011 pp | 0.00% +0.000 pp | USD11.04 -5.6% | 3 qtrs — |
| 87 | ADAR1 CAPITAL MANAGEMENT, LLC | 21.8K +21.8K (+100.0%) | 227.2K +227.2K (+100.0%) | 0.05% +0.053 pp | 0.02% +0.017 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 88 | METLIFE INVESTMENT MANAGEMENT, LLC | 21.8K +— (+0.0%) | 226.7K +31.1K (+15.9%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD28.44 -63.4% | 15 qtrs — |
| 89 | CAPROCK GROUP, LLC | 21.2K +2.3K (+12.1%) | 221.4K +50.0K (+29.2%) | 0.05% +0.005 pp | 0.00% +0.001 pp | USD9.14 +14.0% | 2 qtrs — |
| 90 | INVESCO LTD. | 20.1K +1.2K (+6.6%) | 209.6K +40.0K (+23.6%) | 0.05% +0.003 pp | 0.00% +0.000 pp | USD44.85 -76.8% | 12 qtrs — |
| 91 | SIMPLEX TRADING, LLC | 19.8K -3.6K (-15.2%) | 206.3K -2.7K (-1.3%) | 0.05% -0.009 pp | 0.00% +0.000 pp | USD8.99 +15.9% | 2 qtrs — |
| 92 | AXQ CAPITAL, LP | 19.7K -7.4K (-27.2%) | 205.7K -38.0K (-15.6%) | 0.05% -0.018 pp | 0.05% -0.047 pp | USD13.00 -19.8% | 3 qtrs — |
| 93 | TUDOR INVESTMENT CORP ET AL | 19.3K +19.3K (+100.0%) | 201.2K +201.2K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD10.42 +0.0% | 11 qtrs — |
| 94 | ROYAL BANK OF CANADA | 19.3K -475.1K (-96.1%) | 201.0K -4.2M (-95.5%) | 0.05% -1.166 pp | 0.00% -0.001 pp | USD32.56 -68.0% | 18 qtrs — |
| 95 | IHT WEALTH MANAGEMENT, LLC | 17.6K -3.5K (-16.6%) | 183.5K -6.3K (-3.3%) | 0.04% -0.009 pp | 0.00% 0.000 pp | USD16.43 -36.6% | 18 qtrs — |
| 96 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 16.1K -44.0 (-0.3%) | 168.2K +22.7K (+15.6%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD52.31 -80.1% | 7 qtrs — |
| 97 | CENTIVA CAPITAL, LP | 15.6K +15.6K (+100.0%) | 162.1K +162.1K (+100.0%) | 0.04% +0.038 pp | 0.00% +0.001 pp | USD10.42 +0.0% | 1 qtrs NEW |
| 98 | WINTON GROUP LTD | 15.5K +15.5K (+100.0%) | 161.0K +161.0K (+100.0%) | 0.04% +0.038 pp | 0.01% +0.006 pp | USD10.42 +0.0% | 3 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 55 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.04% | 661.9K | 0.60% |
| 2 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.02% | 209.2K | 0.20% |
| 3 | Xtrackers - Xtrackers MSCI World Swap UCITS ETF 4C - EUR Hedged XWEH.DE | 0.02% | 2.67M | 0.39% |
| 4 | Xtrackers MSCI World Swap UCITS ETF 1C XMWD.L | 0.02% | 2.67M | 0.45% |
| 5 | iShares Russell 2000 Value ETF IWN | 0.01% | 1.64M | 0.24% |
| 6 | Vanguard Russell 2000 Growth ETF VTWG | 0.01% | 192.6K | 0.06% |
| 7 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.01% | 462.1K | 0.30% |
| 8 | Invesco RAFI US 1500 Small-Mid ETF PRFZ | 0.01% | 201.5K | 0.34% |
| 9 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 3.6K | 0.39% |
| 10 | Global X - Russell 2000 ETF RSSL | 0.01% | 92.3K | 0.08% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.50
Neutral
Ratio by volume
3.00
Bullish
Buys
3
Sells
2
Shares acquired
59.1K
Shares disposed
18.0K
Cash buys
—
Cash sales
—
Net activity
+41,084
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 12,489 | 4.13 | 51.6K | 78,180 | D | ↗ |
| 2026-02-28 | Wilterding Mark | Officer | M-Exempt | D | Restricted Stock Unit | 20,441 | 0.00 | — | 143,087 | D | ↗ |
| 2026-02-28 | Gaines Scott | Officer | M-Exempt | A | Common Stock | 6,261 | 0.00 | — | 17,428 | D | ↗ |
| 2026-02-27 | Weinberg Eric | Officer | A-Award | A | Restricted Stock Unit | 32,218 | 0.00 | — | 32,218 | D | ↗ |
| 2026-02-27 | Kurtz Ronald M MD | Director / Officer | A-Award | A | Restricted Stock Unit | 80,545 | 0.00 | — | 80,545 | D | ↗ |
| 2026-02-27 | Goldshleger Ilya | Officer | A-Award | A | Restricted Stock Unit | 32,218 | 0.00 | — | 32,218 | D | ↗ |
| 2026-02-27 | Gaines Scott | Officer | A-Award | A | Restricted Stock Unit | 32,218 | 0.00 | — | 32,218 | D | ↗ |
| 2026-01-12 | Wilterding Mark | Officer | A-Award | A | Stock Option (right to buy) | 258,770 | 10.09 | 2.61M | 258,770 | D | ↗ |
| 2026-01-11 | Wilterding Mark | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-18 | Gaines Scott | Officer | — | — | Common Stock | 0 | 0.00 | — | 11,167 | D | ↗ |
| 2025-09-25 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 8,349 | 4.13 | 34.5K | 12,494 | D | ↗ |
| 2025-07-31 | COHEN RAYMOND W | Director | A-Award | A | Common Stock | 35,668 | 0.00 | — | 35,668 | D | ↗ |
| 2025-06-03 | Warner Robert Keith | Director | A-Award | A | Common Stock | 10,752 | 0.00 | — | 41,039 | D | ↗ |
| 2025-06-03 | Tammenoms Bakker Juliet | Director | A-Award | A | Common Stock | 10,752 | 0.00 | — | 48,146 | D | ↗ |
| 2025-06-03 | PALMISANO ROBERT J | Director | A-Award | A | Common Stock | 10,752 | 0.00 | — | 41,039 | D | ↗ |
| 2025-06-03 | Maniar Shweta | Director | A-Award | A | Common Stock | 10,752 | 0.00 | — | 18,135 | D | ↗ |
| 2025-06-03 | LINK WILLIAM J PHD | Director | A-Award | A | Common Stock | 10,752 | 0.00 | — | 37,855 | D | ↗ |
| 2025-06-03 | Fountain Tamara | Director | A-Award | A | Common Stock | 10,752 | 0.00 | — | 35,545 | D | ↗ |
| 2025-06-03 | Corley Jesse Anderson | Director | A-Award | A | Common Stock | 10,752 | 0.00 | — | 49,190 | D | ↗ |
| 2025-06-03 | Andrews Julie | Director | A-Award | A | Common Stock | 10,752 | 0.00 | — | 41,039 | D | ↗ |
| 2025-06-02 | Weinberg Eric | Officer | M-Exempt | D | Stock Option (right to buy) | 188,002 | 3.93 | 738.8K | 0 | D | ↗ |
| 2025-04-14 | Thunen Shelley B | Officer | M-Exempt | D | Stock Option (right to buy) | 1,387 | 4.34 | 6.0K | 0 | D | ↗ |
| 2025-03-12 | Fountain Tamara | Director | S-Sale | D | Common Stock | 7,000 | 25.71 | 180.0K | 24,793 | D | ↗ |
| 2025-02-27 | Weinberg Eric | Officer | A-Award | A | Stock Option (right to buy) | 125,000 | 28.21 | 3.53M | 125,000 | D | ↗ |
| 2025-02-27 | Thunen Shelley B | Officer | A-Award | A | Stock Option (right to buy) | 125,000 | 28.21 | 3.53M | 125,000 | D | ↗ |
| 2025-02-27 | Kurtz Ronald M MD | Director / Officer | A-Award | A | Stock Option (right to buy) | 215,000 | 28.21 | 6.07M | 215,000 | D | ↗ |
| 2025-02-27 | Goldshleger Ilya | Officer | A-Award | A | Stock Option (right to buy) | 125,000 | 28.21 | 3.53M | 125,000 | D | ↗ |
| 2025-01-22 | Maniar Shweta | Director | S-Sale | D | Common Stock | 3,519 | 30.87 | 108.6K | 7,383 | D | ↗ |
| 2025-01-16 | Corley Jesse Anderson | Director | P-Purchase | A | Common Stock | 1,767 | 31.13 | 55.0K | 3,210 | I | ↗ |
| 2025-01-15 | Corley Jesse Anderson | Director | P-Purchase | A | Common Stock | 1,443 | 31.19 | 45.0K | 1,443 | I | ↗ |
| 2024-11-29 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,105 | 15.08 | 46.8K | 40,777 | D | ↗ |
| 2024-11-26 | Maniar Shweta | Director | S-Sale | D | Common Stock | 3,782 | 45.88 | 173.5K | 10,902 | D | ↗ |
| 2024-11-26 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 3,100 | 15.08 | 46.7K | 45,346 | D | ↗ |
| 2024-11-22 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 46,982 | D | ↗ |
| 2024-11-18 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 50,082 | D | ↗ |
| 2024-11-15 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 4,875 | 15.08 | 73.5K | 53,182 | D | ↗ |
| 2024-11-13 | Corley Jesse Anderson | Director | P-Purchase | A | Common Stock | 5,570 | 45.00 | 250.7K | 474,141 | I | ↗ |
| 2024-11-12 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 1,330 | 46.13 | 61.4K | 42,246 | D | ↗ |
| 2024-11-12 | Corley Jesse Anderson | Director | P-Purchase | A | Common Stock | 11,111 | 45.37 | 504.1K | 468,571 | I | ↗ |
| 2024-11-07 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 59,387 | D | ↗ |
| 2024-11-04 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 62,487 | D | ↗ |
| 2024-10-30 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,105 | 15.08 | 46.8K | 65,587 | D | ↗ |
| 2024-10-28 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 3,100 | 15.08 | 46.7K | 45,346 | D | ↗ |
| 2024-10-25 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 71,792 | D | ↗ |
| 2024-10-22 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 74,892 | D | ↗ |
| 2024-10-18 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,105 | 15.08 | 46.8K | 77,992 | D | ↗ |
| 2024-10-16 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 3,100 | 15.08 | 46.7K | 45,346 | D | ↗ |
| 2024-10-14 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 3,100 | 50.09 | 155.3K | 42,246 | D | ↗ |
| 2024-10-11 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 3,100 | 50.19 | 155.6K | 42,246 | D | ↗ |
| 2024-10-10 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 3,105 | 48.82 | 151.6K | 42,246 | D | ↗ |
| 2024-10-08 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 93,502 | D | ↗ |
| 2024-10-04 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 206 | 48.65 | 10.0K | 42,246 | D | ↗ |
| 2024-10-01 | Thunen Shelley B | Officer | S-Sale | D | Common Stock | 9,521 | 48.69 | 463.6K | 30,721 | D | ↗ |
| 2024-09-30 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 99,702 | D | ↗ |
| 2024-09-26 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,105 | 15.08 | 46.8K | 102,802 | D | ↗ |
| 2024-09-23 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 2,950 | 52.62 | 155.2K | 42,396 | D | ↗ |
| 2024-09-20 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 3,100 | 53.19 | 164.9K | 42,246 | D | ↗ |
| 2024-09-17 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 3,100 | 15.08 | 46.7K | 112,107 | — | ↗ |
| 2024-08-09 | Kurtz Ronald M MD | Director / Officer | M-Exempt | A | Common Stock | 2,300 | 4.34 | 10.0K | 63,450 | — | ↗ |
| 2024-08-07 | Weinberg Eric | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 46.24 | 2.31M | 50,000 | — | ↗ |
| 2024-08-07 | Thunen Shelley B | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 46.24 | 2.31M | 50,000 | — | ↗ |
| 2024-08-07 | Goldshleger Ilya | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 46.24 | 2.31M | 50,000 | — | ↗ |
| 2024-08-05 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 1,087 | 38.83 | 42.2K | 47,159 | — | ↗ |
| 2024-07-15 | Thunen Shelley B | Officer | M-Exempt | A | Common Stock | 16,505 | 4.34 | 71.6K | 30,443 | — | ↗ |
| 2024-07-11 | Kurtz Ronald M MD | Director / Officer | M-Exempt | A | Common Stock | 13,500 | 15.08 | 203.6K | 53,500 | — | ↗ |
| 2024-07-01 | Thunen Shelley B | Officer | S-Sale | D | Common Stock | 1,854 | 59.48 | 110.3K | 13,938 | — | ↗ |
| 2024-06-14 | Andrews Julie | Director | S-Sale | D | Common Stock | 11,940 | 57.84 | 690.6K | 33,972 | — | ↗ |
| 2024-06-06 | Warner Robert Keith | Director | A-Award | A | Common Stock | 2,554 | 0.00 | — | 30,287 | — | ↗ |
| 2024-06-06 | Tammenoms Bakker Juliet | Director | A-Award | A | Common Stock | 2,554 | 0.00 | — | 37,394 | — | ↗ |
| 2024-06-06 | PALMISANO ROBERT J | Director | A-Award | A | Common Stock | 2,554 | 0.00 | — | 30,287 | — | ↗ |
| 2024-06-06 | Maniar Shweta | Director | A-Award | A | Common Stock | 2,554 | 0.00 | — | 14,684 | — | ↗ |
| 2024-06-06 | LINK WILLIAM J PHD | Director | A-Award | A | Common Stock | 2,554 | 0.00 | — | 27,103 | — | ↗ |
| 2024-06-06 | Fountain Tamara | Director | A-Award | A | Common Stock | 2,554 | 0.00 | — | 31,793 | — | ↗ |
| 2024-06-06 | Corley Jesse Anderson | Director | A-Award | A | Common Stock | 2,554 | 0.00 | — | 32,643 | — | ↗ |
| 2024-06-06 | Andrews Julie | Director | A-Award | A | Common Stock | 2,554 | 0.00 | — | 45,912 | — | ↗ |
| 2024-05-17 | Tammenoms Bakker Juliet | Director | P-Purchase | A | Common Stock | 5,000 | 61.09 | 305.5K | 34,840 | — | ↗ |
| 2024-05-17 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 4,264 | 4.34 | 18.5K | 51,246 | — | ↗ |
| 2024-05-03 | Kurtz Ronald M MD | Director / Officer | S-Sale | D | Common Stock | 40,000 | 60.15 | 2.41M | 764,610 | — | ↗ |
| 2024-05-01 | Thunen Shelley B | Officer | S-Sale | D | Common Stock | 9,620 | 52.68 | 506.8K | 14,318 | — | ↗ |
| 2024-04-01 | Thunen Shelley B | Officer | S-Sale | D | Common Stock | 8,857 | 49.81 | 441.2K | 19,545 | — | ↗ |
| 2024-03-04 | Weinberg Eric | Officer | A-Award | A | Stock Option (right to buy) | 92,200 | 56.07 | 5.17M | 92,200 | — | ↗ |
| 2024-03-04 | Thunen Shelley B | Officer | A-Award | A | Stock Option (right to buy) | 92,200 | 56.07 | 5.17M | 92,200 | — | ↗ |
| 2024-03-04 | Kurtz Ronald M MD | Director / Officer | A-Award | A | Stock Option (right to buy) | 149,000 | 56.07 | 8.35M | 149,000 | — | ↗ |
| 2024-03-04 | Goldshleger Ilya | Officer | A-Award | A | Stock Option (right to buy) | 92,200 | 56.07 | 5.17M | 92,200 | — | ↗ |
| 2024-03-01 | Thunen Shelley B | Officer | S-Sale | D | Common Stock | 1,166 | 54.95 | 64.1K | 22,525 | — | ↗ |
| 2024-02-16 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 10,000 | 23.04 | 230.4K | 36,475 | — | ↗ |
| 2024-02-15 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 5,000 | 53.00 | 265.0K | 31,475 | — | ↗ |
| 2024-02-14 | Tammenoms Bakker Juliet | Director | P-Purchase | A | Common Stock | 4,000 | 51.29 | 205.2K | 29,840 | — | ↗ |
| 2024-02-14 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 5,000 | 23.04 | 115.2K | 31,475 | — | ↗ |
| 2024-02-12 | Tammenoms Bakker Juliet | Director | P-Purchase | A | Common Stock | 4,000 | 50.38 | 201.5K | 25,840 | — | ↗ |
| 2024-02-09 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 5,365 | 18.90 | 101.4K | 31,840 | — | ↗ |
| 2024-02-06 | Thunen Shelley B | Officer | M-Exempt | A | Common Stock | 15,875 | 14.95 | 237.3K | 29,566 | — | ↗ |
| 2024-02-05 | Thunen Shelley B | Officer | M-Exempt | A | Common Stock | 9,125 | 14.95 | 136.4K | 22,816 | — | ↗ |
| 2024-02-05 | Corley Jesse Anderson | Director | G-Gift | D | Common Stock | 7,083 | 0.00 | — | 0 | — | ↗ |
| 2024-02-01 | Weinberg Eric | Officer | S-Sale | D | Common Stock | 10,000 | 50.00 | 500.0K | 299,978 | — | ↗ |
| 2024-02-01 | LINK WILLIAM J PHD | Director | G-Gift | D | Common Stock | 3,000 | 0.00 | — | 21,248 | — | ↗ |
| 2024-02-01 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 6,539 | 18.90 | 123.6K | 33,014 | — | ↗ |
| 2024-01-26 | Thunen Shelley B | Officer | M-Exempt | D | Stock Option (right to buy) | 4,500 | 4.34 | 19.5K | 24,540 | — | ↗ |
| 2024-01-22 | Weinberg Eric | Officer | S-Sale | D | Common Stock | 10,000 | 48.00 | 480.0K | 309,978 | — | ↗ |
| 2024-01-22 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 5,000 | 18.90 | 94.5K | 31,475 | — | ↗ |
| 2024-01-18 | Maniar Shweta | Director | S-Sale | D | Common Stock | 3,520 | 45.69 | 160.8K | 15,009 | — | ↗ |
| 2024-01-09 | Weinberg Eric | Officer | S-Sale | D | Common Stock | 10,000 | 46.00 | 460.0K | 319,978 | — | ↗ |
| 2024-01-09 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 18.90 | 94.5K | 14,360 | — | ↗ |
| 2024-01-08 | Weinberg Eric | Officer | S-Sale | D | Common Stock | 10,000 | 42.00 | 420.0K | 329,978 | — | ↗ |
| 2024-01-08 | Warner Robert Keith | Director | S-Sale | D | Common Stock | 16,530 | 42.37 | 700.4K | 7,220 | — | ↗ |
| 2024-01-08 | Maniar Shweta | Director | S-Sale | D | Common Stock | 6,418 | 45.00 | 288.8K | 18,529 | — | ↗ |
| 2024-01-08 | Kurtz Ronald M MD | Director / Officer | S-Sale | D | Common Stock | 31,250 | 45.00 | 1.41M | 804,610 | — | ↗ |
| 2024-01-08 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 5,000 | 45.00 | 225.0K | 26,475 | — | ↗ |
| 2024-01-08 | Corley Jesse Anderson | Director | S-Sale | D | Common Stock | 2,000 | 45.03 | 90.1K | 11,625 | — | ↗ |
| 2024-01-02 | Thunen Shelley B | Officer | M-Exempt | A | Common Stock | 10,000 | 15.60 | 156.0K | 12,291 | — | ↗ |
| 2023-12-27 | Kurtz Ronald M MD | Director / Officer | S-Sale | D | Common Stock | 22,500 | 41.09 | 924.5K | 867,110 | — | ↗ |
| 2023-12-22 | Weinberg Eric | Officer | S-Sale | D | Common Stock | 1,285 | 40.00 | 51.4K | 339,978 | — | ↗ |
| 2023-12-22 | Goldshleger Ilya | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 15.08 | 75.4K | 130,207 | — | ↗ |
| 2023-12-18 | Goldshleger Ilya | Officer | S-Sale | D | Common Stock | 5,000 | 39.09 | 195.5K | 26,475 | — | ↗ |
| 2023-12-15 | Weinberg Eric | Officer | S-Sale | D | Common Stock | 8,715 | 40.01 | 348.7K | 341,263 | — | ↗ |
| 2023-12-15 | Thunen Shelley B | Officer | M-Exempt | D | Stock Option (right to buy) | 20,000 | 15.60 | 312.0K | 76,805 | — | ↗ |
| 2023-12-14 | Kurtz Ronald M MD | Director / Officer | S-Sale | D | Common Stock | 20,000 | 39.40 | 788.0K | 889,610 | — | ↗ |
| 2023-12-14 | Corley Jesse Anderson | Director | S-Sale | D | Common Stock | 2,000 | 40.12 | 80.2K | 13,625 | — | ↗ |
| 2023-12-11 | Warner Robert Keith | Director | S-Sale | D | Common Stock | 5,498 | 35.08 | 192.8K | 23,750 | — | ↗ |
| 2023-12-08 | Warner Robert Keith | Director | S-Sale | D | Common Stock | 14,502 | 35.01 | 507.7K | 29,248 | — | ↗ |
| 2023-11-30 | Tammenoms Bakker Juliet | Director | J-Other | A | Common Stock | 1,617 | 0.00 | — | 21,840 | — | ↗ |
| 2023-11-29 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 349,245 | 29.77 | 10.40M | 0 | — | ↗ |
| 2023-11-28 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 145,068 | 29.62 | 4.30M | 349,245 | — | ↗ |
| 2023-11-15 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 400,000 | 27.20 | 10.88M | 494,313 | — | ↗ |
| 2023-11-14 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 100,000 | 27.13 | 2.71M | 894,313 | — | ↗ |
| 2023-11-13 | Corley Jesse Anderson | Director | J-Other | A | Common Stock | 45,680 | 0.00 | — | 76,973 | — | ↗ |
| 2023-09-11 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 2,950 | 30.01 | 88.5K | 20,223 | — | ↗ |
| 2023-09-08 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 10,033 | 30.25 | 303.5K | 23,173 | — | ↗ |
| 2023-09-07 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 19,967 | 30.10 | 601.0K | 33,206 | — | ↗ |
| 2023-08-29 | Maniar Shweta | Director | S-Sale | D | Common Stock | 4,292 | 28.06 | 120.5K | 24,947 | — | ↗ |
| 2023-08-25 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 16,208 | 29.25 | 474.1K | 53,173 | — | ↗ |
| 2023-08-24 | Tammenoms Bakker Juliet | Director | J-Other | D | Common Stock | 267,300 | 0.00 | — | 445,400 | — | ↗ |
| 2023-08-18 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 14,651 | 29.07 | 425.9K | 68,411 | — | ↗ |
| 2023-08-17 | Tammenoms Bakker Juliet | Director | S-Sale | D | Common Stock | 18,484 | 30.06 | 555.7K | 83,062 | — | ↗ |
| 2023-08-17 | LINK WILLIAM J PHD | Director | J-Other | A | Common Stock | 21,248 | 0.00 | — | 52,498 | — | ↗ |
| 2023-08-17 | Corley Jesse Anderson | Director | J-Other | A | Common Stock | 81,450 | 0.00 | — | 81,450 | — | ↗ |
| 2023-08-09 | Tammenoms Bakker Juliet | Director | J-Other | D | Common Stock | 497,150 | 0.00 | — | 994,313 | — | ↗ |
| 2023-07-26 | Goldshleger Ilya | Officer | M-Exempt | A | Common Stock | 25,475 | 3.93 | 100.0K | 26,475 | — | ↗ |
| 2023-06-14 | Tammenoms Bakker Juliet | Director | J-Other | A | Common Stock | 1,022 | 0.00 | — | 68,596 | — | ↗ |
| 2023-06-01 | Warner Robert Keith | Director | A-Award | A | Common Stock | 5,731 | 0.00 | — | 27,733 | — | ↗ |
| 2023-06-01 | Tammenoms Bakker Juliet | Director | A-Award | A | Common Stock | 5,731 | 0.00 | — | 67,574 | — | ↗ |
| 2023-06-01 | PALMISANO ROBERT J | Director | A-Award | A | Common Stock | 5,731 | 0.00 | — | 27,733 | — | ↗ |
| 2023-06-01 | Maniar Shweta | Director | A-Award | A | Common Stock | 5,731 | 0.00 | — | 29,239 | — | ↗ |
| 2023-06-01 | LINK WILLIAM J PHD | Director | A-Award | A | Common Stock | 5,731 | 0.00 | — | 21,939 | — | ↗ |
| 2023-06-01 | Fountain Tamara | Director | A-Award | A | Common Stock | 5,731 | 0.00 | — | 29,239 | — | ↗ |
| 2023-06-01 | Corley Jesse Anderson | Director | A-Award | A | Common Stock | 5,731 | 0.00 | — | 30,089 | — | ↗ |
| 2023-06-01 | Andrews Julie | Director | A-Award | A | Common Stock | 5,731 | 0.00 | — | 43,358 | — | ↗ |
| 2023-05-26 | Tammenoms Bakker Juliet | Director | J-Other | A | Common Stock | 33,135 | 0.00 | — | 61,843 | — | ↗ |
| 2023-05-11 | LINK WILLIAM J PHD | Director | J-Other | A | Common Stock | 98,715 | 0.00 | — | 694,124 | — | ↗ |
| 2023-03-09 | Weinberg Eric | Officer | A-Award | A | Stock Option (right to buy) | 95,000 | 14.95 | 1.42M | 95,000 | — | ↗ |
| 2023-03-09 | Thunen Shelley B | Officer | A-Award | A | Stock Option (right to buy) | 120,000 | 14.95 | 1.79M | 120,000 | — | ↗ |
| 2023-03-09 | Kurtz Ronald M MD | Director / Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 14.95 | 2.99M | 200,000 | — | ↗ |
| 2023-03-09 | Goldshleger Ilya | Officer | A-Award | A | Stock Option (right to buy) | 120,000 | 14.95 | 1.79M | 120,000 | — | ↗ |
| 2023-02-10 | Tammenoms Bakker Juliet | Director | P-Purchase | A | Common Stock | 480,000 | 12.50 | 6.00M | 980,000 | — | ↗ |
| 2023-02-10 | Kurtz Ronald M MD | Director / Officer | A-Award | A | Common Stock | 40,000 | 12.50 | 500.0K | 40,000 | — | ↗ |
| 2023-01-19 | Fountain Tamara | Director | A-Award | A | Common Stock | 4,312 | 0.00 | — | 23,508 | — | ↗ |
| 2022-11-09 | LINK WILLIAM J PHD | Director | J-Other | D | Common Stock | 316,694 | 0.00 | — | 258,390 | — | ↗ |
| 2022-08-10 | LINK WILLIAM J PHD | Director | J-Other | D | Common Stock | 316,694 | 0.00 | — | 575,084 | — | ↗ |
| 2022-06-08 | LINK WILLIAM J PHD | Director | J-Other | D | Common Stock | 375,000 | 0.00 | — | 891,778 | — | ↗ |
| 2022-06-02 | Warner Robert Keith | Director | A-Award | A | Common Stock | 8,624 | 0.00 | — | 22,002 | — | ↗ |
| 2022-06-02 | Tammenoms Bakker Juliet | Director | A-Award | A | Common Stock | 10,349 | 0.00 | — | 28,708 | — | ↗ |
| 2022-06-02 | PALMISANO ROBERT J | Director | A-Award | A | Common Stock | 8,624 | 0.00 | — | 22,002 | — | ↗ |
| 2022-06-02 | Maniar Shweta | Director | A-Award | A | Common Stock | 4,312 | 0.00 | — | 23,508 | — | ↗ |
| 2022-06-02 | LINK WILLIAM J PHD | Director | A-Award | A | Common Stock | 10,349 | 0.00 | — | 47,458 | — | ↗ |
| 2022-06-02 | Corley Jesse Anderson | Director | A-Award | A | Common Stock | 10,349 | 0.00 | — | 24,358 | — | ↗ |
| 2022-06-02 | Andrews Julie | Director | A-Award | A | Common Stock | 8,624 | 0.00 | — | 37,627 | — | ↗ |
| 2022-05-17 | LINK WILLIAM J PHD | Director | J-Other | D | Common Stock | 375,000 | 0.00 | — | 1,266,778 | — | ↗ |
| 2022-03-15 | LINK WILLIAM J PHD | Director | J-Other | A | Common Stock | 126,979 | 0.00 | — | 126,979 | — | ↗ |
| 2022-01-03 | Maniar Shweta | Director | A-Award | A | Common Stock | 19,196 | 0.00 | — | 19,196 | — | ↗ |
| 2022-01-01 | Fountain Tamara | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Maniar Shweta | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-17 | Corley Jesse Anderson | Director | P-Purchase | A | Common Stock | 8,150 | 12.49 | 101.8K | 14,009 | — | ↗ |
| 2021-08-05 | Weinberg Eric | Officer | P-Purchase | A | Common Stock | 9 | 14.90 | 134.10 | 925 | — | ↗ |
| 2021-08-05 | Kurtz Ronald M MD | Director / Officer | P-Purchase | A | Common Stock | 3,638 | 13.85 | 50.4K | 804,610 | — | ↗ |
| 2021-08-05 | Goldshleger Ilya | Officer | P-Purchase | A | Common Stock | 1,372 | 13.69 | 18.8K | 1,372 | — | ↗ |
| 2021-08-04 | Weinberg Eric | Officer | P-Purchase | A | Common Stock | 615 | 16.25 | 10.0K | 916 | — | ↗ |
| 2021-08-03 | Wolfen Richard M. | Director | C-Conversion | D | Series E Preferred Stock | 18,150 | 0.00 | — | 0 | — | ↗ |
| 2021-08-03 | Weinberg Eric | Officer | P-Purchase | A | Common Stock | 31,250 | 16.00 | 500.0K | 31,250 | — | ↗ |
| 2021-08-03 | Warner Robert Keith | Director | P-Purchase | A | Common Stock | 43,750 | 16.00 | 700.0K | 57,128 | — | ↗ |
| 2021-08-03 | Tammenoms Bakker Juliet | Director | M-Exempt | A | Series H Preferred Stock | 36,302 | 0.00 | — | 36,302 | — | ↗ |
| 2021-08-03 | Schwartz Daniel Mark | Director | C-Conversion | A | Common Stock | 3,969 | 0.00 | — | 407,647 | — | ↗ |
| 2021-08-03 | RxSight I, LLC | 10% Owner | C-Conversion | A | Common Stock | 2,016,778 | 0.00 | — | 2,016,778 | — | ↗ |
| 2021-08-03 | Robertson Bruce C | Director | C-Conversion | D | Series G Preferred Stock | 968,054 | 0.00 | — | 0 | — | ↗ |
| 2021-08-03 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 2,838,938 | — | ↗ |
| 2021-08-03 | PALMISANO ROBERT J | Director | A-Award | A | Common Stock | 7,645 | 0.00 | — | 13,378 | — | ↗ |
| 2021-08-03 | LINK WILLIAM J PHD | Director / 10% Owner | C-Conversion | A | Common Stock | 2,016,778 | 0.00 | — | 2,016,778 | — | ↗ |
| 2021-08-03 | Kurtz Ronald M MD | Director / Officer | P-Purchase | A | Common Stock | 125,000 | 16.00 | 2.00M | 125,000 | — | ↗ |
| 2021-08-03 | Corley Jesse Anderson | Director | P-Purchase | A | Common Stock | 78,125 | 16.00 | 1.25M | 436,201 | — | ↗ |
| 2021-08-03 | Andrews Julie | Director | P-Purchase | A | Common Stock | 15,625 | 16.00 | 250.0K | 29,003 | — | ↗ |
| 2021-08-02 | Weinberg Eric | Officer | P-Purchase | A | Common Stock | 90 | 17.04 | 1.5K | 300 | — | ↗ |
| 2021-07-31 | Weinberg Eric | Officer | A-Award | A | Stock option (right to buy) | 87,437 | 16.00 | 1.40M | 87,437 | — | ↗ |
| 2021-07-31 | Thunen Shelley B | Officer | A-Award | A | Stock option (right to buy) | 98,367 | 16.00 | 1.57M | 98,367 | — | ↗ |
| 2021-07-31 | Kurtz Ronald M MD | Officer | A-Award | A | Stock option (right to buy) | 338,819 | 16.00 | 5.42M | 338,819 | — | ↗ |
| 2021-07-31 | Goldshleger Ilya | Officer | A-Award | A | Stock option (right to buy) | 98,367 | 16.00 | 1.57M | 98,367 | — | ↗ |
| 2021-07-30 | Weinberg Eric | Officer | P-Purchase | A | Common Stock | 210 | 16.94 | 3.6K | 210 | — | ↗ |
| 2021-07-30 | Tammenoms Bakker Juliet | Director | A-Award | A | Common Stock | 5,859 | 0.00 | — | 5,859 | — | ↗ |
| 2021-07-30 | LINK WILLIAM J PHD | Director | A-Award | A | Common Stock | 5,859 | 0.00 | — | 5,859 | — | ↗ |
| 2021-07-30 | Corley Jesse Anderson | Director | A-Award | A | Common Stock | 5,859 | 0.00 | — | 5,859 | — | ↗ |
| 2021-07-29 | Wolfen Richard M. | Director | — | I | Series C Preferred Stock | 398,810 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Weinberg Eric | Officer | — | I | Common Stock | 0 | 0.00 | — | 318,728 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-78.0K
Shares Outstanding
41.27M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Ron Kurtz, M.D. Chief Executive Officer, President and Director | 630.6K | — | — | 3.82M | 202.9K | 571.00 | 4.65M | 82.06% | ↗ |
| 2 | 2025 | Eric Weinberg Chief Business Development Officer | 520.4K | — | — | 2.22M | 108.8K | 7.0K | 2.86M | 77.72% | ↗ |
| 3 | 2025 | Shelley Thunen Former Chief Financial Officer | 520.4K | — | — | 2.22M | 108.8K | 7.0K | 2.86M | 77.72% | ↗ |
| 4 | 2025 | Ilya Goldshleger, Ph.D. Chief Operating Officer | 520.4K | — | — | 2.22M | 108.8K | 4.8K | 2.85M | 77.78% | ↗ |
| 5 | 2025 | Scott Gaines Chief Customer Officer | 401.7K | — | 448.7K | 455.5K | 64.6K | 5.8K | 1.38M | 65.70% | ↗ |
| 6 | 2024 | Ron Kurtz, M.D. Chief Executive Officer, President and Director | 678.3K | — | — | 5.54M | 759.7K | 6.5K | 6.98M | 79.31% | ↗ |
| 7 | 2024 | Ron Kurtz, M.D. Chief Executive Officer and President, Director | 678.3K | — | — | 5.54M | 759.7K | 6.5K | 6.98M | 79.31% | ↗ |
| 8 | 2024 | Ilya Goldshleger, Ph.D. Co-President and Chief Operating Officer | 503.8K | — | — | 4.92M | 366.7K | 29.4K | 5.82M | 84.54% | ↗ |
| 9 | 2024 | Ilya Goldshleger, Ph.D. Chief Operating Officer | 503.8K | — | — | 4.92M | 366.7K | 29.4K | 5.82M | 84.54% | ↗ |
| 10 | 2024 | Eric Weinberg Co-President and Chief Commercial Officer | 503.8K | — | — | 4.92M | 366.7K | 6.9K | 5.80M | 84.86% | ↗ |
| 11 | 2024 | Eric Weinberg Chief Business Development Officer | 503.8K | — | — | 4.92M | 366.7K | 6.9K | 5.80M | 84.86% | ↗ |
| 12 | 2024 | Shelley Thunen Former Chief Financial Officer | 503.8K | — | — | 4.92M | 366.7K | 6.9K | 5.80M | 84.86% | ↗ |
| 13 | 2024 | Shelley Thunen Co-President and Chief Financial Officer | 503.8K | — | — | 4.92M | 366.7K | 6.9K | 5.80M | 84.86% | ↗ |
| 14 | 2023 | Ron Kurtz, M.D. Chief Executive Officer and President, Director | 633.3K | — | — | 1.87M | 570.0K | 4.6K | 3.08M | 60.80% | ↗ |
| 15 | 2023 | Ron Kurtz, M.D Chief Executive Officer and President, Director | 633.3K | — | — | 1.87M | 570.0K | 4.6K | 3.08M | 60.80% | ↗ |
| 16 | 2023 | Ron Kurtz, M.D. Chief Executive Officer, President and Director | 633.3K | — | — | 1.87M | 570.0K | 4.6K | 3.08M | 60.80% | ↗ |
| 17 | 2023 | Shelley Thunen Co-President and Chief Financial Officer | 454.2K | — | — | 1.12M | 295.2K | 12.8K | 1.89M | 59.59% | ↗ |
| 18 | 2023 | Shelley Thunen Chief Financial Officer | 454.2K | — | — | 1.12M | 295.2K | 12.8K | 1.89M | 59.59% | ↗ |
| 19 | 2023 | Shelley Thunen Former Chief Financial Officer | 454.2K | — | — | 1.12M | 295.2K | 12.8K | 1.89M | 59.59% | ↗ |
| 20 | 2023 | Ilya Goldshleger, Ph.D. Co-President and Chief Operating Officer | 454.2K | — | — | 1.12M | 295.2K | 12.1K | 1.89M | 59.62% | ↗ |
| 21 | 2023 | Ilya Goldshleger, Ph.D. Chief Operating Officer | 454.2K | — | — | 1.12M | 295.2K | 12.1K | 1.89M | 59.62% | ↗ |
| 22 | 2023 | Eric Weinberg Co-President and Chief Commercial Officer | 454.2K | — | — | 890.0K | 295.2K | 13.4K | 1.65M | 53.85% | ↗ |
| 23 | 2023 | Eric Weinberg Chief Commercial Officer | 454.2K | — | — | 890.0K | 295.2K | 13.4K | 1.65M | 53.85% | ↗ |
| 24 | 2023 | Eric Weinberg Chief Business Development Officer | 454.2K | — | — | 890.0K | 295.2K | 13.4K | 1.65M | 53.85% | ↗ |
| 25 | 2022 | Ron Kurtz, M.D Chief Executive Officer and President, Director | 562.5K | — | — | — | 457.6K | 5.4K | 1.03M | 0.00% | ↗ |
| 26 | 2022 | Ron Kurtz, M.D. Chief Executive Officer and President, Director | 562.5K | — | — | — | 457.6K | 5.4K | 1.03M | 0.00% | ↗ |
| 27 | 2022 | Ilya Goldshleger, Ph.D. Co-President and Chief Operating Officer | 416.7K | — | — | — | 219.3K | 21.8K | 657.8K | 0.00% | ↗ |
| 28 | 2022 | Ilya Goldshleger, Ph.D. Chief Operating Officer | 416.7K | — | — | — | 219.3K | 21.8K | 657.8K | 0.00% | ↗ |
| 29 | 2022 | Shelley Thunen Chief Financial Officer | 416.7K | — | — | — | 223.7K | 11.0K | 651.4K | 0.00% | ↗ |
| 30 | 2022 | Shelley Thunen Co-President and Chief Financial Officer | 416.7K | — | — | — | 223.7K | 11.0K | 651.4K | 0.00% | ↗ |
| 31 | 2022 | Eric Weinberg Chief Commercial Officer | 416.7K | — | — | — | 214.0K | 8.2K | 638.9K | 0.00% | ↗ |
| 32 | 2022 | Eric Weinberg Co-President and Chief Commercial Officer | 416.7K | — | — | — | 214.0K | 8.2K | 638.9K | 0.00% | ↗ |
| 33 | 2021 | Ron Kurtz, M.D Chief Executive Officer and President, Director | 445.3K | — | — | 3.97M | 375.0K | 30.8K | 4.83M | 82.36% | ↗ |
| 34 | 2021 | Ilya Goldshleger, Ph.D. Chief Operating Officer | 357.4K | — | — | 1.77M | 187.5K | 26.7K | 2.35M | 75.64% | ↗ |
| 35 | 2021 | Shelley Thunen Chief Financial Officer | 344.3K | — | — | 1.77M | 187.5K | 4.9K | 2.31M | 76.78% | ↗ |
| 36 | 2021 | Eric Weinberg Chief Commercial Officer | 358.8K | — | — | 1.67M | 187.5K | 29.3K | 2.25M | 74.42% | ↗ |
| 37 | 2020 | Ilya Goldshleger, Ph.D. Chief Operating Officer | 287.1K | 45.0K | — | 1.21M | — | — | 1.54M | 78.50% | ↗ |
| 38 | 2020 | Eric Weinberg Chief Commercial Officer | 272.6K | 45.0K | — | 606.2K | — | — | 923.7K | 65.62% | ↗ |
| 39 | 2020 | Ron Kurtz, M.D Chief Executive Officer and President, Director | 309.6K | 27.0K | — | 404.1K | — | — | 740.7K | 54.56% | ↗ |
| 40 | 2020 | Shelley Thunen Chief Financial Officer | 250.5K | 45.0K | — | 404.1K | — | — | 699.6K | 57.76% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Eric J. Weinberg | Chief Business Development Officer | 3M | male |
| Mark Wilterding | Chief Financial Officer | 877.4K | male |
| Ronald Kurtz | President, Chief Executive Officer & Director | 834.1K | — |
| Ilya Goldshleger | Chief Operating Officer | 634.0K | — |
| Patrick Cullen | Executive Vice President of Quality & Infrastructure Operations | — | male |
| Adam Dashe | Executive Vice President of International | — | male |
| Scott Gaines | Chief Customer Officer | — | male |
| Jim Schindler | Executive VP & General Counsel | — | male |
| Maureen O'Connell | Executive Vice President of Clinical & Regulatory Affairs | — | female |
| Oliver Moravcevic | Vice President of Investor Relations | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RXST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
